Head-to-head clinical trials comparing semaglutide and tirzepatide have generally shown tirzepatide producing somewhat greater average weight loss
Examination and initial investigations Recommended minimum evaluation for new or worsening vaginal symptoms in a semaglutide-treated patient generally mirrors standard care: External vulvar inspection for dermatoses (lichen sclerosus, eczema/contact dermatitis), fissures, atrophy signs
00:04:51 Vickie Danaher But the GLP-1 agonists for obesity have all been injectable up until now
Working in a chaotic or unprepared environment is a recipe for error
Although the prescription drug is FDA approved for diabetes, it is being prescribed off-label for weight loss, necessitating careful monitoring of health risks such as high blood pressure, high cholesterol, sleep apnea, and problems digesting food